Acceptability of HPV-self Sampling
Evaluation of the Acceptability of HPV Self-sampling Among French Women Eligible for Cervical Cancer Screening
1 other identifier
observational
356
1 country
1
Brief Summary
This trial aimed at evaluating the acceptability of HPV self-sampling among french women eligible for cervical cancer screening (25 - 65 years old) in the region of Occitanie, in the south of France. Acceptability will be evaluated using an anonymous questionnaire and the main outcome of the study will be the response acceptability " yes " or " no " for HPV self-sampling. Secondary outcome will be analysis of socioeconomic determinants for the acceptability of HPV self-sampling. These data will help to propose new strategies for cervical cancer screening in France, particularly to taget non-attenting populations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2017
CompletedFirst Posted
Study publicly available on registry
May 2, 2017
CompletedStudy Start
First participant enrolled
May 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2019
CompletedDecember 31, 2020
December 1, 2020
3 months
April 28, 2017
December 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
accept HPV self-sampling for cervical cancer
Response " Yes " or " No " to the question " would you accept HPV self-sampling for cervical cancer screening ?
1 day
Secondary Outcomes (1)
Socioeconomic determinants of the response
1 day
Study Arms (1)
Women eligible for cervical cancer screening
French women aged 25 to 65 years living in the Department of Hérault or Aude (France), attending one of the 8 centers where the questionnaire will be distributed
Interventions
The questionnaire will be distributed and collected by the same investigator in one of the eight centers involved in the study. The investigator will verify the inclusion criteria and the absence of exclusion criteria.
Eligibility Criteria
Women attending 8 centers of the Departments of Hearault and Aude : social medical cares, Department of gynecology in the hospitals of Montpellier and Carcassonne ; mid-wifes consultations.
You may qualify if:
- Women 25-65 years old
- Living in the Aude or Herault departments
You may not qualify if:
- Virgins
- Previous hysterectomy
- Present or previous cervical pathology
- Patient under guardianship or tutorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
Related Publications (1)
Bertucci M, Bonnet E, Satger L, Kreiche A, Chappert JL, Loy-Morel S, Segondy M, Daures JP, Boulle N. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study. Women Health. 2021 Jan;61(1):83-94. doi: 10.1080/03630242.2020.1831683. Epub 2020 Oct 26.
PMID: 33106125RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nathalie BOULLE, MD, PhD
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2017
First Posted
May 2, 2017
Study Start
May 15, 2017
Primary Completion
July 30, 2017
Study Completion
July 30, 2019
Last Updated
December 31, 2020
Record last verified: 2020-12